These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21502263)

  • 41. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?
    Mekinian A; Cohen J; Alijotas-Reig J; Carbillon L; Nicaise-Roland P; Kayem G; Daraï E; Fain O; Bornes M
    Am J Reprod Immunol; 2016 Jul; 76(1):8-28. PubMed ID: 26847715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A systematic review of dydrogesterone for the treatment of recurrent miscarriage.
    Carp H
    Gynecol Endocrinol; 2015 Jun; 31(6):422-30. PubMed ID: 25765519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more.
    Cohain JS; Buxbaum RE; Mankuta D
    BMC Pregnancy Childbirth; 2017 Dec; 17(1):437. PubMed ID: 29272996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progesterone profiles in luteal phase defect cycles and outcome of progesterone treatment in patients with recurrent spontaneous abortion.
    Daya S; Ward S; Burrows E
    Am J Obstet Gynecol; 1988 Feb; 158(2):225-32. PubMed ID: 3341399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial.
    Ismail AM; Abbas AM; Ali MK; Amin AF
    J Matern Fetal Neonatal Med; 2018 Feb; 31(3):388-394. PubMed ID: 28114846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
    Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
    Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
    Lu C; Liu Y; Jiang HL
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid Peroxidase Antibodies and Prospective Live Birth Rate: A Cohort Study of Women with Recurrent Pregnancy Loss.
    Bliddal S; Feldt-Rasmussen U; Rasmussen ÅK; Kolte AM; Hilsted LM; Christiansen OB; Nielsen CH; Nielsen HS
    Thyroid; 2019 Oct; 29(10):1465-1474. PubMed ID: 31407629
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last.
    Romero R
    Womens Health (Lond); 2011 Sep; 7(5):501-4. PubMed ID: 21879816
    [No Abstract]   [Full Text] [Related]  

  • 51. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study.
    Pasquier E; de Saint-Martin L; Marhic G; Chauleur C; Bohec C; Bretelle F; Lejeune-Saada V; Hannigsberg J; Plu-Bureau G; Cogulet V; Merviel P; Mottier D
    BMJ Open; 2019 Mar; 9(3):e025649. PubMed ID: 30898821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of hormonal treatment in threatened and habitual abortion].
    Tarlantas D; Moschovakis K
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):563-4. PubMed ID: 5935246
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of progesterone therapy in early pregnancy: from physiological role to therapeutic utility.
    Czyzyk A; Podfigurna A; Genazzani AR; Meczekalski B
    Gynecol Endocrinol; 2017 Jun; 33(6):421-424. PubMed ID: 28277122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Synthetic progestogens versus oral progesterone].
    Alonso-Uriarte R; Cortés-Gallegos V
    Ginecol Obstet Mex; 1991 Feb; 59():50-8. PubMed ID: 2066005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calibrated Automated Thrombogram During Pregnancy in Unexplained Recurrent Miscarriages: A Pilot Study.
    Elias A; Hamoudi R; Schwartz N; Ron G; Elias M
    Isr Med Assoc J; 2019 Oct; 21(10):681-685. PubMed ID: 31599511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Habitual abortion.
    Glass RH; Golbus MS
    Fertil Steril; 1978 Mar; 29(3):257-65. PubMed ID: 346382
    [No Abstract]   [Full Text] [Related]  

  • 57. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.
    Suhag A; Saccone G; Berghella V
    Am J Obstet Gynecol; 2015 Oct; 213(4):479-87. PubMed ID: 25797233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009154. PubMed ID: 26148507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.
    Clifford K; Rai R; Watson H; Franks S; Regan L
    BMJ; 1996 Jun; 312(7045):1508-11. PubMed ID: 8646142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of low molecular weight heparin on obstetric outcomes among unexplained recurrent miscarriages complicated with methylenetetrahydrofolate reductase gene polymorphism.
    Cetin O; Karaman E; Cim N; Dirik D; Sahin HG; Kara E; Esen R
    Ginekol Pol; 2017; 88(5):260-265. PubMed ID: 28580572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.